These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 27062389
1. Central nervous system involvement in AIDS-related lymphomas. Barta SK, Joshi J, Mounier N, Xue X, Wang D, Ribera JM, Navarro JT, Hoffmann C, Dunleavy K, Little RF, Wilson WH, Spina M, Galicier L, Noy A, Sparano JA. Br J Haematol; 2016 Jun; 173(6):857-66. PubMed ID: 27062389 [Abstract] [Full Text] [Related]
2. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study. Cai QQ, Hu LY, Geng QR, Chen J, Lu ZH, Rao HL, Liu Q, Jiang WQ, Huang HQ, Lin TY, Xia ZJ. Chin J Cancer; 2016 Sep 13; 35(1):87. PubMed ID: 27624700 [Abstract] [Full Text] [Related]
3. Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab. Tai WM, Chung J, Tang PL, Koo YX, Hou X, Tay KW, Quek R, Tao M, Lim ST. Ann Hematol; 2011 Jul 13; 90(7):809-18. PubMed ID: 21229246 [Abstract] [Full Text] [Related]
4. Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma. Tomita N, Kodama F, Kanamori H, Motomura S, Ishigatsubo Y. Cancer; 2002 Aug 01; 95(3):576-80. PubMed ID: 12209750 [Abstract] [Full Text] [Related]
5. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia. Robotin MC, Law MG, Milliken S, Goldstein D, Garsia RJ, Dolan GM, Kaldor JM, Grulich AE. HIV Med; 2004 Sep 01; 5(5):377-84. PubMed ID: 15369514 [Abstract] [Full Text] [Related]
6. Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers. Jurczak W, Kroll-Balcerzak R, Giebel S, Machaczka M, Giza A, Ogórka T, Fornagiel S, Rybka J, Wróbel T, Kumiega B, Skotnicki AB, Komarnicki M. Med Oncol; 2015 Apr 01; 32(4):90. PubMed ID: 25716885 [Abstract] [Full Text] [Related]
7. High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement. Kasamon YL, Jones RJ, Piantadosi S, Ambinder RF, Abrams RA, Borowitz MJ, Morrison C, Smith BD, Flinn IW. Biol Blood Marrow Transplant; 2005 Feb 01; 11(2):93-100. PubMed ID: 15682069 [Abstract] [Full Text] [Related]
8. Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era. Kridel R, Telio D, Villa D, Sehn LH, Gerrie AS, Shenkier T, Klasa R, Slack GW, Tan K, Gascoyne RD, Connors JM, Savage KJ. Br J Haematol; 2017 Jan 01; 176(2):210-221. PubMed ID: 27739058 [Abstract] [Full Text] [Related]
9. Highly active antiretroviral therapy is associated with improved survival among patients with AIDS-related primary central nervous system non-Hodgkin's lymphoma. Diamond C, Taylor TH, Im T, Miradi M, Wallace M, Anton-Culver H. Curr HIV Res; 2006 Jul 01; 4(3):375-8. PubMed ID: 16842088 [Abstract] [Full Text] [Related]
10. [Therapeutic management of central nervous system lymphomas in a single hematological institute]. Iványi JL, Marton E, Plander M, Gyánó G, Czumbil L, Tóth C. Orv Hetil; 2009 Oct 18; 150(42):1937-44. PubMed ID: 19812012 [Abstract] [Full Text] [Related]
11. Secondary central nervous system relapse in diffuse large B cell lymphoma in a resource limited country: result from the Thailand nationwide multi-institutional registry. Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Chuncharunee S, Niparuck P, Ekwattanakit S, Khuhapinant A, Norasetthada L, Nawarawong W, Makruasi N, Kanitsap N, Sirijerachai C, Chansung K, Wong P, Numbenjapon T, Prayongratana K, Suwanban T, Wongkhantee S, Praditsuktavorn P, Intragumtornchai T, Thai Lymphoma Study Group. Ann Hematol; 2017 Jan 18; 96(1):57-64. PubMed ID: 27752821 [Abstract] [Full Text] [Related]
12. Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration. Cheah CY, Bröckelmann PJ, Chihara D, Moskowitz AJ, Engert A, Jerkeman M, El-Galaly TC, Augustson B, Vose J, Bartlett NL, Villa D, Connors JM, Feldman T, Pinnix CC, Milgrom SA, Dabaja B, Oki Y, Fanale MA. Am J Hematol; 2016 Sep 18; 91(9):894-9. PubMed ID: 27222367 [Abstract] [Full Text] [Related]
13. Central nervous system prophylaxis in diffuse large B-cell lymphoma. Zahid MF, Khan N, Hashmi SK, Kizilbash SH, Barta SK. Eur J Haematol; 2016 Aug 18; 97(2):108-20. PubMed ID: 27096423 [Abstract] [Full Text] [Related]
14. Radiation therapy for HIV-associated diffuse large cell non-Hodgkin lymphoma. Rothschild S, Dolder M, Seifert B, Lütolf UM, Ciernik IF. J Int Assoc Physicians AIDS Care (Chic); 2009 Aug 18; 8(4):239-48. PubMed ID: 19589920 [Abstract] [Full Text] [Related]
15. Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature. Guirguis HR, Cheung MC, Mahrous M, Piliotis E, Berinstein N, Imrie KR, Zhang L, Buckstein R. Br J Haematol; 2012 Oct 18; 159(1):39-49. PubMed ID: 22849793 [Abstract] [Full Text] [Related]
16. Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice. Jurczyszyn A, Grzasko N, Gozzetti A, Czepiel J, Cerase A, Hungria V, Crusoe E, Silva Dias AL, Vij R, Fiala MA, Caers J, Rasche L, Nooka AK, Lonial S, Vesole DH, Philip S, Gangatharan S, Druzd-Sitek A, Walewski J, Corso A, Cocito F, Vekemans MC, Atilla E, Beksac M, Leleu X, Davila J, Badros A, Aneja E, Abildgaard N, Kastritis E, Fantl D, Schutz N, Pika T, Butrym A, Olszewska-Szopa M, Usnarska-Zubkiewicz L, Usmani SZ, Nahi H, Chim CS, Shustik C, Madry K, Lentzsch S, Swiderska A, Helbig G, Guzicka-Kazimierczak R, Lendvai N, Waage A, Andersen KT, Murakami H, Zweegman S, Castillo JJ. Am J Hematol; 2016 Jun 18; 91(6):575-80. PubMed ID: 26955792 [Abstract] [Full Text] [Related]
17. Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients. Wyen C, Jensen B, Hentrich M, Siehl J, Sabranski M, Esser S, Gillor D, Müller M, Van Lunzen J, Wolf T, Bogner JR, Wasmuth JC, Christ H, Fätkenheuer G, Hoffmann C. AIDS; 2012 Feb 20; 26(4):457-64. PubMed ID: 22112600 [Abstract] [Full Text] [Related]
18. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group. Reman O, Pigneux A, Huguet F, Vey N, Delannoy A, Fegueux N, de Botton S, Stamatoullas A, Tournilhac O, Buzyn A, Charrin C, Boucheix C, Gabert J, Lhéritier V, Vernant JP, Fière D, Dombret H, Thomas X, GET-LALA group. Leuk Res; 2008 Nov 20; 32(11):1741-50. PubMed ID: 18508120 [Abstract] [Full Text] [Related]
19. Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era. Ferreri AJ, Bruno-Ventre M, Donadoni G, Ponzoni M, Citterio G, Foppoli M, Vignati A, Scarfò L, Sassone M, Govi S, Caligaris-Cappio F. Br J Haematol; 2015 Mar 20; 168(5):654-62. PubMed ID: 25312994 [Abstract] [Full Text] [Related]
20. Implications and Management of Central Nervous System Involvement before Allogeneic Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia. Aldoss I, Al Malki MM, Stiller T, Cao T, Sanchez JF, Palmer J, Forman SJ, Pullarkat V. Biol Blood Marrow Transplant; 2016 Mar 20; 22(3):575-8. PubMed ID: 26493564 [Abstract] [Full Text] [Related] Page: [Next] [New Search]